Top Banner
54

Cell inj 1

Jul 14, 2015

Download

Documents

Taha Faruqui
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Cell inj 1
Page 2: Cell inj 1

What is pathology ?

General Pathology

Systemic / Special Pathology

Page 3: Cell inj 1

Any disease process will have:

1. Etiology 2. Pathogenesis3. Morphologic changes4. Signs & symptoms (clinical features)5. Diagnosis, prognosis, treatment & prevention

Page 4: Cell inj 1

Physiologic stimulus / Pathologic stimulus

Cellular adaptation

Cell Injury

Normal cell Reversible Irreversible injury

Cell Death

Page 5: Cell inj 1
Page 6: Cell inj 1
Page 7: Cell inj 1

Factors influencing cellular response to an

injurious stimulus:

1. Type of injurious agent

2. Duration of stimulus

3. Type of target cell

4. Status (nutritional & metabolic) of target cell

Page 8: Cell inj 1

Response of a cell to injury can be in the form of:

1. Cellular adaptations2. Acute cell injury – reversible & irreversible3. Intra cellular accumulations (metabolic derangements)4. Pathologic calcification5. Aging

Page 9: Cell inj 1

Atrophy Hypertrophy Hyperplasia Metaplasia

Page 10: Cell inj 1

Defined as increase in cell size with concomitant increase in size of tissue or organs

Increased synthesis of structural proteins & organelles

Page 11: Cell inj 1

Hypertrophy is usually associated with hyperplasia in stable cells

Pure hypertrophy occurs in heart & skeletal muscles (non-dividing permanent cells)

Page 12: Cell inj 1

Physiologic hypertrophy occur in:

◦ Skeletal muscles (weight lifters) - Mechanical

◦ Uterine muscles (pregnancy) – Hormonal

◦ Mammary glands (pregnancy) – Hormonal

Page 13: Cell inj 1

Pathologic hypertrophy occur in:

◦Heart (hypertension, post-MI) – Mechanical◦ Smooth muscle (achalasia in esophagus,

pyloric stenosis) – Mechanical◦ Kidney (following nephrectomy) –

Compensatory◦ Liver – Compensatory or drug-induced

Page 14: Cell inj 1
Page 15: Cell inj 1
Page 16: Cell inj 1
Page 17: Cell inj 1

Defined as an increase in number of cells with proportionate increase in size of tissue or organ

Occur in labile cells & stable cells

Usually associated with hypertrophy

Predisposition to cancer

Page 18: Cell inj 1

Physiologic hyperplasia:1. Hormonal e.g.i. Gravid uterusii. Female breast (pregnancy & puberty)2. Compensatory – Parenchymal e.g.i. Liver (influence of GF)3. Compensatory – Mesenchymal e.g.i. Fibroblasts & blood vessels (wound healing)

Page 19: Cell inj 1
Page 20: Cell inj 1

Pathologic Hyperplasia:

1. Endometrial hyperplasia (hormonal)2. Skin wart (HPV – GF)

3. Prostate hyperplasia (hormonal)

Page 21: Cell inj 1

PROSTATE HYPERPLASIA

Testosterone Dihydrotestosterone (DHT)

↑ age --- ↑ ↑ estrogen --- ↑ expression of DHT receptors on prostatic parenchymal cells --- DHT binds to receptors --- Prostate Hyperplasia

Page 22: Cell inj 1
Page 23: Cell inj 1
Page 24: Cell inj 1
Page 25: Cell inj 1
Page 26: Cell inj 1

Defined as replacement of one adult cell type (either epithelial or mesenchymal) by another adult cell type.

Reversible initially

Page 27: Cell inj 1
Page 28: Cell inj 1

Epithelial metaplasia predispose to malignant transformation

Normal cell Metaplasia Cancer

Page 29: Cell inj 1

Epithelial Metaplasia (columnar to squamous):

1. Cigarette smokers (trachea & bronchi)2. Vitamin A deficiency (respiratory epithelium)

Page 30: Cell inj 1

Epithelial Metaplasia (squamous to columnar):1. Barrett esophagus

Page 31: Cell inj 1
Page 32: Cell inj 1

Mesenchymal Metaplasia:

Osseous metaplasia in foci of injury

Page 33: Cell inj 1
Page 34: Cell inj 1

Decrease in size of cells, tissues or organs Both nucleus & cytoplasm reduced in size Causes include:

1. Disuse atrophy2. Denervation atrophy

Page 35: Cell inj 1

3. Loss of hormonal stimulation4. Ischemia5. Malnutrition (PEM)6. Aging (senile atrophy) Mechanism – Decreased protein synthesis &

increased protein degradation

Page 36: Cell inj 1

Protein degradation occurs through:

i. Ubiquitin - Proteasome pathway --- degrade cytosolic & nuclear proteins

ii. Autophagy

Page 37: Cell inj 1
Page 38: Cell inj 1
Page 39: Cell inj 1
Page 40: Cell inj 1
Page 41: Cell inj 1
Page 42: Cell inj 1
Page 43: Cell inj 1

Abnormal accumulation of triglycerides in parenchymal cells

Seen in:1. Liver (mostly)2. Heart3. Skeletal muscles4. Kidney etc.

Reversible injury

Page 44: Cell inj 1

Causes:

Toxins (CCl4, chloroform, aflatoxins, poisons) Protein malnutrition Diabetes mellitus Obesity Pregnancy Alcohol abuse Starvation Anemia (hypoxia) Reye syndrome

Page 45: Cell inj 1

Pathogenesis

Page 46: Cell inj 1

Morphology:

Liver:

◦Gross --Enlarged, yellow, soft & greasy

◦M/s --- Microvesicular change

Macrovesicular change Fatty cysts

Page 47: Cell inj 1
Page 48: Cell inj 1
Page 49: Cell inj 1

Heart:◦Gross --- In anemia --- “tigered effect” In diphtheria --- uniform effect

◦M/s features --- same as above

Page 50: Cell inj 1

Phagocytic cells engulf cholesterol --- foam cells e.g.

1. Atherosclerosis 2. Xanthomas (Hyperlipidemic syndrome)

Page 51: Cell inj 1
Page 52: Cell inj 1

Causes of protein deposition include:

1. Nephrotic syndrome2. Russell bodies 3. Mallory bodies (alcohol )4. Neurofibrillary tangles in Alzheimer disease

Page 53: Cell inj 1
Page 54: Cell inj 1

Causes of glycogen deposition include:1. Diabetes mellitus2. Glycogen storage diseases hepatic type --- Von Gierke’s disease

(deficiency of glucose-6-phosphatase) myopathic type --- McArdle’s disease

(deficiency of muscle phosphorylase) Pompe disease --- deficiency of lysosomal

acid maltase